Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

High doses of finasteride cause cell growth and tumors in mice.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.